Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages

AIDS

Volumn 12, Issue 9, 1998, Pages 977-984

  Ylisastigui, Loyda ^a   Vizzavona, Jean ^b   Drakopoulou, Eugenia ^b   Paindavoine, Pascale ^c   Calvo, Charles Felix ^d   Parmentier, Marc ^e   Gluckman, Jean Claude ^a   Vita, Claudio ^b   Benjouad, Abdelaziz ^a,f,g  

^a Unit of Dermatology   (France)

^b DIF   (France)

^c Euroscreen   (Belgium)

^d l'alimentation et l'Environnement   (France)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f FACULTÉ DES SCIENCES   (Morocco)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Chemokine antagonists; Coreceptor; Drugs; HIV; Macrophages

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; RANTES;

AMINO TERMINAL SEQUENCE; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032543650     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199809000-00004     Document Type: Article

References (35)

1. Chun TW, Carruth L, Finzi D, et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
2. Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE: Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 1990, 8:169-194.
3. Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS: CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocytes/macrophages. Proc Natl Acad Sci USA 1996, 93:15341-15345.
4. Deng H, Liu R, Ellmeier W, et al.: Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
5. Dragic T, Litwin V, Allaway CP, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
6. Samson M, Labbé O, Mollereau C, Vassart G, Parmentier M: Molecular cloning and functional expression of new human CC-chemokine receptor gene. Biochemistry 1996, 35:3362-3367.
7. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-876.
8. Alkhatib G, Combadire C, Broder CC, et al.: CC CKR-5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
9. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
10. Rucker J, Samson M, Doranz BJ, et al.: Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996, 87:437-446.
11. Cocchi F, DeVico AL, Garzino-Demo A, Ary SK, Gallo RC, Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
12. Arenzana-Seisdedos F, Virelizier JL, Rousset D, et al.: HIV blocked by chemokine antagonist [letter]. Nature 1996, 383:400.
13. Schmidtmayerova H, Sherry B, Bukrinsky M: Chemokines and HIV replication [letter]. Nature 1996, 382:67.
14. Simmons G, Clapham PR, Picard L, et al.: Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997, 276:276-279.
15. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993, 57:183-289.
16. Baggiolini M, Moser B: Blocking chemokine receptors. J Exp Med 1997, 186:1189-1191.
17. Fields CG, Lloyd DH, MacDonald RL, Otteson KM, Noble RL: HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res 1991, 4:91-101.
18. Calvo CF, Yoshimura T, Gelman M, Mallat M: Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur J Neurosci 1996, 8:1725-1734.
19. Gartner S, Markovits P, Markovits DM, Kaplan MH, Gallo RC: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-219.
20. Gendelman HE, Orenstein JM, Martin MA, et al.: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony stimulating factor 1-treated monocytes. J Exp Med 1988, 167:1428-1441.
21. Benjouad A, Seddiki N, Ylisastigui L, Gluckman JC: HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages. AIDS Res Hum Retroviruses 1997, 13:219-226.
22. Valentin A, Von Gegerfelt A, Matsuda S, Nilsson K, Asjö B: In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 1991, 4:451-759.
23. Atherton E, Sheppard RC: Solid Phase Peptide Synthesis. Oxford: IRL Press; 1989.
24. Skelton NJ, Aspiras F, Ogez J, Schall T: Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry 1995, 34:5329-5342.
25. Chung C, Cooke RM, Proudfoot AEI, Wells TNC: The three-dimensional solution structure of RANTES. Biochemistry 1995, 34:9307-9314.
26. Patel SR, Evans S, Dunne K, et al.: Characterisation of the quaternary structure and conformational properties of the human stem cell inhibitor protein LD78 in solution. Biochemistry 1993, 32:5466-5471.
27. Samson M, LaRosa G, Libert F, et al.: The second intracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 1997, 272:24934-24941.
28. Schall TJ, Bacon K, Toy KJ, Goedded DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990, 347:669-671.
29. Verani A, Scarlatti G, Comar M, et al.: C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 1997, 185:805-816.
30. Samson M, Libert F, Doranz BJ, et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
31. Gong JH, Uguccioni M, Dewad B, Baggiolini M, Clark-Lewis I: RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 1996, 271:10521-10527.
32. Pakianathan DR, Kuta EG, Artis DR, Skelton NJ, Hebert CA: Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5. Biochemistry 1997, 36:9642-9648.
33. Amara A, Le Gall S, Schwartz O, et al.: HIV coreceptor down-regulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997, 186:139-146.
34. Oravecz T, Pall M, Roderiquez G, et al.: Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 1997, 186:1865-1872.
35. Oravecz T, Pall M, Wang J, Roderiquez G, Ditto M, Norcross MA: Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J Immunol 1997, 159:4587-4592.